secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2023-03-29T23:59:59+00:00
Accession:  0001213900-23-024081
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma regains NYSE American price compliance but remains under equity plan with delisting risk
--------------------------------------------------------------------------------

- Resolved low selling price deficiency via 1-for-10 reverse stock split on March 6, 2023.
- Still non-compliant with stockholders' equity standards (Sections 1003(a)(ii) and (iii)).
- Must achieve full compliance by December 15, 2023 or face delisting proceedings.
- ".BC" indicator remains on ticker CPHI.
- If average share price falls below $0.20 over 30 days, immediate review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390023024081/0001213900-23-024081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390023024081/ea175993-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-024081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer